Here, recent developments of an IgG1-Fc-fusion protein with RNase1, designated RSLV-132, proved its availability in phase-II studies of inflammatory diseases such as Sjögren's syndrome [35, 304]. Here, RNASE1 is linked to Sjogren syndrome.